320 filings
10-K/A
2023 FY
NAOV
NanoVibronix Inc
Annual report (amended)
26 Apr 24
4:05pm
8-K
NAOV
NanoVibronix Inc
15 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
10-K/A
2023 FY
NAOV
NanoVibronix Inc
Annual report (amended)
9 Apr 24
5:15pm
8-K
NAOV
NanoVibronix Inc
9 Apr 24
NanoVibronix Issues Letter to Stockholders
4:05pm
10-K
2023 FY
NAOV
NanoVibronix Inc
Annual report
8 Apr 24
5:30pm
NT 10-K
i3j33v
1 Apr 24
Notice of late annual filing
4:30pm
8-K
oni4b z1nojpb2wv12v2
28 Mar 24
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
9:09am
DEFA14A
9f4j3ro
17 Jan 24
Additional proxy soliciting materials
4:31pm
8-K
gv8lack2d rsxft
17 Jan 24
Other Events
4:30pm
8-K
m03 9dudhghwhh0
11 Dec 23
Changes in Registrant's Certifying Accountant
4:30pm
8-K
u55f4x
4 Dec 23
Departure of Directors or Certain Officers
4:45pm
DEFA14A
1c7ex7q4mn1co3n7g
29 Nov 23
Additional proxy soliciting materials
8:43pm
8-K
be1zjwb6
28 Nov 23
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
9:00am
8-K
5ojfkrvv
21 Nov 23
Other Events
8:30am
8-K
wgo3j0frti1zzfxmxks
14 Nov 23
NanoVibronix Issues Letter to Shareholders
12:00am
8-K
k3q17smpk
7 Nov 23
Receives Stocking Order from U.K. Distribution Partner in Anticipation of Increasing Demand
8:30am
8-K
5y4401j8376kz xddsfz
27 Sep 23
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
8:00am
EFFECT
72xyjoezqmsasr4gz7v
22 Sep 23
Notice of effectiveness
12:15am